Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Chinese Journal of Cardiology
>
2011
>
39
>
2
Volume:
39
Issue:
2
1. Metabolic imaging of myocardial ischemia.
Page:188—190
2. Non-invasive diagnostic tools and clinical classification of cardiac amyloidosis: state of the art.
Page:185—187
3. Update on cardiac SCN5A gene mutation and dilated cardiomyopathy.
Page:182—184
4. One case of stent malapposition and intima hyperplasia 3 years after stent deployment detected by optical coherence tomography.
Page:181—181
5. Association between myocardial connexin 40 and 45 expression and myocardial fibrosis in the rapid atrial pacing canine model.
Page:176—180
6. Investigation on long-term survival of transplanted bone marrow mesenchymal stem cells in infarcted myocardium of rats.
Page:171—175
7. Time course of C4a and platelet aggregation rates in no-reflow patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Page:168—170
8. Clinical features of patients with pulmonary artery hypertension associated with hereditary hemorrhagic telangiectasia.
Page:164—167
9. Survey of influencing factors on smoking and cessation compliance in patients after coronary artery bypass graft surgery.
Page:160—163
10. Clinical implication of microvasculopathy in patients post heart transplantation.
Page:156—159
11. Clinical characteristics of fat replacement of left ventricular myocardium.
Page:152—155
12. Increased small conductance calcium-activated potassium channel (SK2 channel) current in atrial myocytes of patients with persistent atrial fibrillation.
Page:147—151
13. Clinical implication and association between local and systemic levels of interleukin-1β and interleukin-10 in patients with coronary artery disease.
Page:142—146
14. Vulnerable plaque burden post pharmacological and interventional treatments in patients with acute coronary syndrome and borderline lesion: intravascular ultrasound follow up results.
Page:137—141
15. Circadian blood pressure variability and plasma neopterin level before and after surgery for obstructive sleep apnea syndrome.
Page:132—136
16. Clinical follow-up of staged hybrid approach for patients with ventricular septal defects combined with patent ductus arteriosus and pulmonary hypertension.
Page:128—131
17. The efficacy and safety of bosentan therapy for Chinese patients with idiopathic pulmonary arterial hypertension: an open-label, prospective multicenter study.
Page:124—127
18. Effects of matrix metalloproteinase-9 inhibitor in Lewis rats with experimental autoimmune myocarditis.
Page:118—123
19. Outcome post orthotopic heart transplantation for patients with end-stage hypertrophic cardiomyopathy.
Page:114—117
20. Screening and analysis of the mutations on beta-myosin heavy chain gene in 3 Chinese families with hypertrophic cardiomyopathy.
Page:110—113
21. Clinical features and prognosis of 188 Chinese patients with apical hypertrophic cardiomyopathy.
Page:106—109
22. Diagnosed left ventricular hypertrophy by ECG in hypertension patients: the value and strategy.
Page:105—105
23. Challenge and chance in research, diagnosis and treatment of hypertrophic cardiomyopathy.
Page:101—104
24. Some concerns about ionizing radiation for diagnostic studies.
Page:97—100
